Profound Medical Corp. (PROF)
NASDAQ: PROF · IEX Real-Time Price · USD
-0.03 (-0.31%)
At close: Jul 17, 2024, 3:57 PM
+0.07 (0.72%)
After-hours: Jul 17, 2024, 4:00 PM EDT

Profound Medical Revenue

Profound Medical had revenue of $5.33M in the twelve months ending March 31, 2024, with 2.49% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.40M with 4.20% year-over-year growth. In the year 2023, Profound Medical had annual revenue of $5.41M with 10.99% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
237.94M USD

Revenue Chart

* The company reports in CAD currency but revenue data is shown in USD.


Fiscal Year End Revenue Change Growth
Dec 31, 20235.41M536.14K10.99%
Dec 31, 20224.88M-492.89K-9.18%
Dec 31, 20215.37M-359.10K-6.27%
Dec 31, 20205.73M2.54M79.79%
Dec 31, 20193.19M1.26M65.30%
Dec 31, 20181.93M-1.93M-49.97%
Dec 31, 20173.85M--
Dec 31, 20160--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Auna SA 1.08B
Codexis 74.23M
2seventy bio 71.20M
bluebird bio 21.73M
Delcath Systems 4.61M
Abeona Therapeutics 3.50M
Fractyl Health 148.00K
Actinium Pharmaceuticals 81.00K
Revenue Rankings